Economy News Ozempic Maker Novo Nordisk Isn T Just Europe S Second Most Valuable Company It Is Also Singlehandedly Boosting Denmark S Economy

How Novo Nordisk Is Trying to Regain Its Weight-Loss Edge

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their ... Read More

Novo Nordisk to Shake Up Board After Obesity-Market Challenges

The reckoning at Ozempic maker Novo Nordisk isn’t over. The nonprofit foundation that controls the Denmark-based drugmaker forced a shake-up of its board of directors, the latest sign of the ... Read More

Could Novo Nordisk’s New Weight-Loss Pill Be Just What Its Stock Needs?

Novo Nordisk shares surged Tuesday after the company said it received FDA approval for an oral version of its injectable weight-loss drug Wegovy. Read More

Novo Nordisk Faces Setback. Here's What Caused the Ozempic Maker's Stock to Tumble Monday.

Novo Nordisk's U.S.-listed shares are falling sharply Monday after the drugmaker said its latest drug trial was not effective in slowing the progression of Alzheimer's. The company was testing whether ... Read More

How Novo Nordisk Gave Up Its Weight-Loss Gains

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their ... Read More

Drugmaker cuts prices for Ozempic, Wegovy. Here's how much you will pay.

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ... Read More

What's Happening With Novo Nordisk Stock?

CHONGQING, CHINA - SEPTEMBER 10: In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. The maker of Wegovy and Ozempic, ... Read More

Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic for some customers

Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers. Current customers who pay for the drugs out of pocket — without ... Read More

Novo Nordisk to offer select doses of Ozempic, Wegovy at a steep discount

GLP-1 weight loss drugs are still far from cheap, but some of the prices keep dropping. Novo Nordisk is now offering people who pay out of pocket a steep discount for select doses of Ozempic and ... Read More

Novo Nordisk rolls out lower prices for Ozempic and Wegovy

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications. The company announced that through the end ... Read More

Novo Nordisk Faces Setback. Here's What Caused the Ozempic Maker's Stock to Tumble Monday.

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ... Read More